蘇創燃氣(01430.HK):正就解除存款質押合約諮詢法律顧問
蘇創燃氣(01430.HK)公布,獲核數師安永會計師事務所通知,公司兩間附屬公司訂立的若干銀行存款質押未必已於截至2021年6月30日止六個月的中期業績公告所載資料內入賬及披露,董事會已展開調查,以確定該等附屬公司的財務狀況及銀行記錄,並正就盡快解除存款質押合約諮詢其法律顧問。
公司又指,董事會已暫停涉及存款質押合同的相關僱員的工作,並要求該等僱員協助調查,將將繼續調查此事,採取適當行動,並適時作進一步公告。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.